Ironwood Pharmaceuticals, Inc.
IRWD
$1.27
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 107.18% | -54.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 107.18% | -54.56% | |||
| Cost of Revenue | -14.80% | 134.96% | |||
| Gross Profit | 351.21% | -91.89% | |||
| SG&A Expenses | -30.77% | -27.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.29% | -12.36% | |||
| Operating Income | 527.25% | -133.42% | |||
| Income Before Tax | 204.27% | -251.16% | |||
| Income Tax Expenses | 1,176.75% | -94.88% | |||
| Earnings from Continuing Operations | 163.12% | -1,757.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 163.12% | -1,757.18% | |||
| EBIT | 527.25% | -133.42% | |||
| EBITDA | 552.21% | -131.42% | |||
| EPS Basic | 162.83% | -1,746.81% | |||
| Normalized Basic EPS | 311.05% | -172.96% | |||
| EPS Diluted | 159.17% | -1,746.81% | |||
| Normalized Diluted EPS | 293.02% | -172.96% | |||
| Average Basic Shares Outstanding | 0.47% | 0.96% | |||
| Average Diluted Shares Outstanding | 9.85% | 0.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||